News: Alkermes Receives Notice from Eli Lilly Terminating Inhaled …
Friday, December 12th, 2008Alkermes, Inc. (NASDAQ: ALKS) announced that it has received a
letter terminating the development and license agreement between Eli
Lilly and Company (Lilly) and Alkermes dated April 1, 2001 thereby
terminating the AIR(R) Inhaled Insulin (AIR(R) Insulin) program. The
termination will become effective in 90 days. The termination of the
agreement also results in the…
